Evidence map›Paper›PMID 35251037›Full record

ArticleFrontiers in immunology2022

Corrigendum: Assessing the Function of the

Tingting Zhu, Yuandi Huang, Danfeng Qian, Yuming Sheng, Chaowen Zhang, Shirui Chen, Hui Zhang, Hui Wang, Xuejun Zhang, Junlin Liu and 2 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Tingting ZhuDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Yuandi HuangDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Danfeng QianDepartment of Dermatology, Lu'an People's Hospital, Lu'an, China.
Yuming ShengDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Chaowen ZhangDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Shirui ChenDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Hui ZhangDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Hui WangDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Xuejun ZhangDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Junlin LiuDepartment of Dermatology, The Second Affiliated Hospital, Hainan Medical University, Haikou, China.
Changhai DingDepartment of Rheumatology and Immunology, Arthritis Research Institute, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Lu LiuDepartment of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
First Affiliated Hospital of Anhui Medical University · CNAnhui Medical University · CNHainan Medical University · CNLu'an First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.611515.].

Indexed as

eQTLsingle nucleotide polymorphismSLE drug target genessystemic lupus erythematosusZFP90

Identifiers

PMID35251037
PMCPMC8895393
OpenAlexW4213250416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.